Open AI’s CEO says we won’t need new hardware or lots more training data to get there. L. Ron Hubbard, Operation Midnight ...

Two professors from the C.E. Lynn College of Nursing are leading a team of investigators from four other institutions to ...

Otsuka acquired AVP-786 from CNS specialist Avanir Pharmaceuticals in a 2015 buyout worth $3.5 billion. Also coming in that ...

Healthcare & Pharmaceuticalscategory Japan's Otsuka to stop development of Alzheimer's disease drug Japan's Otsuka ...

As an excellent source of heart-healthy omega-3 fatty acids, daily fish oil supplements are a popular way to keep the risk of ...

The annual IG Wealth Management Walk for Alzheimer’s, hosted by the Alzheimer Society Huron Perth ... Dunn said they are optimistic they’ll reach their goal. “This disease is becoming more and more ...

Expert opinion from Sarath Kumar Sar MBBS · 1 years of experience · India Avoid alcohol or keep it in a minimum range. Eat ...

Young-onset dementia, also called early-onset dementia, affects more than 300 thousand Americans. And it strikes during the ...

The goal is to move from treatment to cure. “Someday, maybe, that is the goal, yes,” Skinner said. The Greenwood Genetic Center also recently received state funding to study how the mitochondria plays ...

Alzheimer’s disease is a progressive brain disorder that gradually destroys memory and thinking skills, and eventually, the ability to carry out simple tasks. This debilitating condition affects ...

Researchers have found that 54% of older American Indians have cognitive impairment, including 10% with dementia, highlighting a significant disparity ...

Biogen said Wednesday it will acquire a California biotech that specializes in diseases of the immune system for $1.15 ...